Product Information
Name:DS18561882
Brand:Biosynth
Description:DS18561882 is a mitochondria-targeting drug that can induce apoptotic cell death. It has been shown to be clinically relevant in phase II clinical studies. DS18561882 may be used as a prognostic marker for cancer patients, and it suppresses the expression of genes that promote cell proliferation. This drug also inhibits protein synthesis, which causes apoptosis by targeting the mitochondria. DS18561882 is orally active and can be used as an anticancer agent against solid tumors.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:608.6 g/mol
Formula:C28H31F3N4O6S
Purity:Min. 95%
Technical inquiry about: DS18561882
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.